Institute of Director 's Michael Smith says the Pfizer bid for Astrazeneca has prompted significant political intervention . He says Pfizer 's pursuit of Astrazeneca has stirred up a wave of protectionism , even if it 's a global company . Ultimately the decision is in the hands of the shareholders who will consider the matter carefully .
Institute of Director 's Roger Barker says the Pfizer bid for Astrazeneca has prompted significant political intervention . He said Pfizer 's pursuit of Astrazeneca has stirred up a wealth of protectionism , even if it 's a global company . Ultimately the decision is in the hands of the shareholders who must consider the deal carefully .